Purchase Order 75N98026P00752
- Not listed
- <p>The National Cancer Institute awarded a purchase order to American College of Radiology for $3,939.63 on June 1, 2016, with an ultimate completion date of July 23, 2016. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no set-aside designation. Specific scope details are not provided in the award record.</p>
- <p>The National Cancer Institute awarded a purchase order to Metastat, Inc. for $46,600 on September 21, 2016. The order covers services to examine and analyze MENA signatures within a case-control study of patients with ER-positive breast cancer. Work is performed in Rockville, Maryland. The ultimate completion date is March 25, 2021. This purchase order represents a de-obligation of funds from FY2016 expiring lines.</p>
- <p>The National Cancer Institute awarded a purchase order to Innomics Inc. for $24,449.00 on September 22, 2020, for eukaryotic transcriptome resequencing. Work is performed in Cambridge, Massachusetts, with completion targeted for November 30, 2020. The order is a firm fixed-price acquisition for commercial genomic sequencing and bioinformatics services.</p>
- The National Cancer Institute awarded a purchase order to Outcomes Insights, Inc. for $24,680.00 on August 3, 2015. The order funds extraction, transformation, and loading of Surveillance, Epidemiology, and End Results (SEER) breast cancer data into the Observational Medical Outcomes Partnership (OMOP) Common Data Model in support of the Division of Cancer Control and Population Sciences' Surveillance Informatics Branch. Work is performed in Westlake Village, California, under a firm fixed-price...
- The National Cancer Institute (NCI) awarded a $166,410.58 firm fixed-price purchase order to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The purpose is to procure 620 samples for NCI's Multi-Ancestry Genome-Wide Association Study, with a period of performance from September 25, 2022 through September 24, 2023, and an ultimate completion date of September 25, 2025. This contract has no set-aside designation. Sloan-Kettering Institute for Cancer Research is a...
- <p>The National Cancer Institute awarded a $21,000.00 firm fixed price purchase order to Omapix Inc. for data analysis services to support spatial transcriptomics/molecular cartography data analysis for the Murgai Lab. The contract has an ultimate completion date of August 31, 2024 and does not have a set-aside designation. This award appears to be a discrete purchase of data analysis services and is not associated with a larger contract vehicle.</p>
- <p>The National Cancer Institute awarded a purchase order to the University of California, Los Angeles for $21,139.00 on September 6, 2019. The order procures germline DNA samples and data from renal cell carcinoma patients for use in the National Cancer Institute's Renal Cell Carcinoma Genome-Wide Association Study. Work is performed in Los Angeles, California. The purchase order carries firm fixed-price pricing with an ultimate completion date of December 5, 2020.</p>
- <p>The National Cancer Institute issued a purchase order to National Cancer Center, National Research and Development Agency on May 14, 2026, with a ceiling value of $15,075.00 for firm fixed price commercial items. This order replaces PO 75N91021P00879 to correct the UEI number. Work is performed in Bethesda, Maryland, with an ultimate completion date of May 13, 2027.</p>
- <p>The National Institutes of Health Clinical Center awarded a purchase order to Centre International de Recherche sur le Cancer (IARC) for $22,124.00 on April 23, 2020, for germline DNA samples and data from renal cell carcinoma patients. Performance occurs in France with an ultimate completion date of April 30, 2021. The order is firm fixed price with no set-aside applied.</p>
- The National Cancer Institute issued a delivery order to the Institute for Defense Analyses on September 15, 2014, with a ceiling value of $148,946.92 for the development of evaluation metrics for extramurally funded programs, projects, and initiatives for the Epidemiology and Genomics Research Program. Place of performance is Alexandria, VA. The period of performance runs from September 15, 2014, through December 31, 2017. The order is priced on a cost-plus-fixed-fee basis with no set-aside...
The National Cancer Institute awarded a purchase order to ECOG-ACRIN Medical Research Foundation, Inc. for digital transfer of clinical data and histological slide images, valued at $21,660.69, with an award date of June 15, 2026. Performance is located in Bethesda, Maryland. The order requires application of molecular prediction models to digitized histopathology slides from 1,154 clear cell kidney cancer patients, delivery of path-omic analysis and clinical correlation of the entire patient cohort, and provision of a well-annotated dataset for comparison with ongoing patho-omic analyses. Inferred omics data (bulk RNA gene expression and DNA methylation predictions) will be made available to consortium members. The work is due by December 31, 2026.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Digital transfer of histological slide images and clinical data | 75N98026Q00489 | Department of Health and Human Services National Institutes of Health Office of Logisitics and Acquisition Operations | Pre-Solicitation 1/1 | 6/1/26, 9:40 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.7k | 6/10/26 |